Header Logo

Connection

JOSEPH JANKOVIC to Anti-Dyskinesia Agents

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Anti-Dyskinesia Agents.
JOSEPH JANKOVIC
Connection Strength
5.576
Anti-Dyskinesia Agents
  1. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77.
    View in: PubMed
    Score: 0.492
  2. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52.
    View in: PubMed
    Score: 0.418
  3. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013 Feb 04; 5(2):249-66.
    View in: PubMed
    Score: 0.393
  4. Analysis of CYP2D6 genotype and response to tetrabenazine. Mov Disord. 2013 Feb; 28(2):210-5.
    View in: PubMed
    Score: 0.390
  5. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Eur J Neurol. 2009 Dec; 16 Suppl 2:14-8.
    View in: PubMed
    Score: 0.315
  6. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna). 2008; 115(4):585-91.
    View in: PubMed
    Score: 0.265
  7. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7.
    View in: PubMed
    Score: 0.258
  8. Short-term effects of tetrabenazine on chorea associated with Huntington's disease. Mov Disord. 2007 Jan; 22(1):10-3.
    View in: PubMed
    Score: 0.257
  9. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol. 2006 Sep-Oct; 29(5):259-64.
    View in: PubMed
    Score: 0.252
  10. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Chin Med Sci J. 2005 Mar; 20(1):44-7.
    View in: PubMed
    Score: 0.227
  11. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44.
    View in: PubMed
    Score: 0.219
  12. Treatment of cervical dystonia with botulinum toxin. Mov Disord. 2004 Mar; 19 Suppl 8:S109-15.
    View in: PubMed
    Score: 0.212
  13. Botulinum toxin for the treatment of cervical dystonia. Expert Opin Pharmacother. 2001 Dec; 2(12):1985-94.
    View in: PubMed
    Score: 0.181
  14. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve. 2001 Nov; 24(11):1568-70.
    View in: PubMed
    Score: 0.180
  15. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):337-45.
    View in: PubMed
    Score: 0.176
  16. Botulinum toxin in the treatment of tics. Arch Neurol. 2000 Aug; 57(8):1190-3.
    View in: PubMed
    Score: 0.165
  17. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry. 1999 Aug; 156(8):1279-81.
    View in: PubMed
    Score: 0.154
  18. Medical therapy and botulinum toxin in dystonia. Adv Neurol. 1998; 78:169-83.
    View in: PubMed
    Score: 0.138
  19. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997 Feb; 48(2):358-62.
    View in: PubMed
    Score: 0.130
  20. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997; 6:S129-45.
    View in: PubMed
    Score: 0.129
  21. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83.
    View in: PubMed
    Score: 0.101
  22. Medical treatment of dystonia. Mov Disord. 2013 Jun 15; 28(7):1001-12.
    View in: PubMed
    Score: 0.101
  23. Role of botulinum toxin in the treatment of cervical dystonia. Neurol Clin. 2008 May; 26 Suppl 1:43-53.
    View in: PubMed
    Score: 0.071
  24. Treatment of dystonia. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S362-8.
    View in: PubMed
    Score: 0.064
  25. Runner's dystonia. J Neurol Sci. 2006 Dec 21; 251(1-2):73-6.
    View in: PubMed
    Score: 0.064
  26. Treatment of dystonia. Lancet Neurol. 2006 Oct; 5(10):864-72.
    View in: PubMed
    Score: 0.063
  27. Dystonia in corticobasal degeneration. Mov Disord. 2001 Mar; 16(2):252-7.
    View in: PubMed
    Score: 0.043
  28. Psychogenic hemifacial spasm. J Neuropsychiatry Clin Neurosci. 2001; 13(3):380-4.
    View in: PubMed
    Score: 0.042
  29. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000 Feb; 68(2):186-90.
    View in: PubMed
    Score: 0.040
  30. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry. 1998 Nov; 65(5):722-8.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.